Replies to post #37486 on Ocata Therapeutics Inc fka OCAT

[rocky301]

hi dianne,

of the 5 directors, Rabin is definitely NOT independent
Shapiro, Perry and Loshitzer are independent
Langer, I am not sure about via his deal with ACT.(below)
Either way they meet the BOD requirements for NASDAQ
Todays corp. presentation also shows another BOD is on the way
(slide24) no idea whether new one is independent
http://www.advancedcell.com/documents/0000/0365/act-presentation---biotech-showcase-2012-reg-med-track---final.pdf

" In addition, Mr. Langer will receive for his service on our Science Advisory Committee an annual retainer of $80,000 (payable in quarterly installments of $20,000) plus a fee of $1,500 per meeting. Our board of directors also granted Mr. Langer in connection with his appointment as chair of our Science Advisory Committee an additional 3,000,000 shares of restricted stock and an option to purchase 2,000,000 shares of our common stock, each of which vests one third on October 4, 2011, one third on October 4, 2012 and one third on October 4, 2013."

Robert S. Langer, Sc.D.
Zohar Loshitzer
Gregory D. Perry
Gary Rabin
Alan C. Shapiro, Ph.D.